Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 18, 2019 Filed Jan 23, 2019 21:12 UTC |
Powell LynneSenior VP - CCO
|
SaleCommon Stock | 2,000 | $9.40 | $18,800.00 |
DisclosureSEC source: 0001127602-19-002527 · form4.xml · nonDerivative · entry 2 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:12 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionCommon Stock | 2,000 | $3.22 | $6,440.00 |
DisclosureSEC source: 0001127602-19-002527 · form4.xml · nonDerivative · entry 1 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 16, 2019 Filed Jan 18, 2019 21:03 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 3,046 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-19-002367 · form4.xml · derivative · entry 3 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,427 Underlying: Common Stock · 3,046 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 16, 2019 Filed Jan 18, 2019 21:03 UTC |
Powell LynneSenior VP - CCO
|
SaleCommon Stock | 3,046 | $9.27 | $28,236.42 |
DisclosureSEC source: 0001127602-19-002367 · form4.xml · nonDerivative · entry 2 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.20 to $9.31. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| January 16, 2019 Filed Jan 18, 2019 21:03 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionCommon Stock | 3,046 | $3.22 | $9,808.12 |
DisclosureSEC source: 0001127602-19-002367 · form4.xml · nonDerivative · entry 1 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:24 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 954 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-19-002141 · form4.xml · derivative · entry 3 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,473 Underlying: Common Stock · 954 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:24 UTC |
Powell LynneSenior VP - CCO
|
SaleCommon Stock | 954 | $9.20 | $8,776.80 |
DisclosureSEC source: 0001127602-19-002141 · form4.xml · nonDerivative · entry 2 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:24 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionCommon Stock | 954 | $3.22 | $3,071.88 |
DisclosureSEC source: 0001127602-19-002141 · form4.xml · nonDerivative · entry 1 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 954 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 18:23 UTC |
ASELAGE STEVEDirector
|
GrantNon-Qualified Stock Option · Derivative | 25,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001127602-19-001582 · form4.xml · derivative · entry 1 ASELAGE STEVE · CIK 0001221599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-01-04 F1 · shares: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:38 UTC |
Barnes Alane PSenior VP, Chief Legal Officer
|
Tax withholdingCommon Stock | 423 | $8.07 | $3,413.61 |
DisclosureSEC source: 0001127602-19-000736 · form4.xml · nonDerivative · entry 1 Barnes Alane P · CIK 0001584348 · Senior VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,530 F1 · shares: Shares withheld by BioCryst Pharmaceuticals, Inc. to satisfy the reporting person's withholding obligations upon the vesting of restricted stock units granted in 2015. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:36 UTC |
Babu Yarlagadda SSenior VP - Drug Discovery
|
Tax withholdingCommon Stock | 771 | $8.07 | $6,221.97 |
DisclosureSEC source: 0001127602-19-000730 · form4.xml · nonDerivative · entry 1 Babu Yarlagadda S · CIK 0001452635 · Senior VP - Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,100 F1 · shares: Shares withheld by BioCryst Pharmaceuticals, Inc. to satisfy the reporting person's withholding obligations upon the vesting of restricted stock units granted in 2015. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:30 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Tax withholdingCommon Stock | 785 | $8.07 | $6,334.95 |
DisclosureSEC source: 0001127602-19-000710 · form4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,676 F1 · shares: Shares withheld by BioCryst Pharmaceuticals, Inc. to satisfy the reporting person's withholding obligations upon the vesting of restricted stock units granted in 2015. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:33 UTC |
Sheridan William PSenior VP - CMO
|
Tax withholdingCommon Stock | 1,087 | $8.07 | $8,772.09 |
DisclosureSEC source: 0001127602-19-000720 · form4.xml · nonDerivative · entry 1 Sheridan William P · CIK 0001439174 · Senior VP - CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,638 F1 · shares: Shares withheld by BioCryst Pharmaceuticals, Inc. to satisfy the reporting person's withholding obligations upon the vesting of restricted stock units granted in 2015. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:27 UTC |
Stonehouse Jon PDirector · President & CEO
|
Tax withholdingCommon Stock | 3,568 | $8.07 | $28,793.76 |
DisclosureSEC source: 0001127602-19-000701 · form4.xml · nonDerivative · entry 1 Stonehouse Jon P · CIK 0001385496 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724,106 F1 · shares: Shares withheld by BioCryst Pharmaceuticals, Inc. to satisfy the reporting person's withholding obligations upon the vesting of restricted stock units granted in 2015. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:15 UTC |
Barnes Alane PSenior VP, Chief Legal Officer
|
GrantEmp. Stock Option (Right to Buy) · Derivative | 190,000 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001127602-18-037182 · form4.xml · derivative · entry 1 Barnes Alane P · CIK 0001584348 · Senior VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2028-12-20 F1 · shares: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:10 UTC |
Babu Yarlagadda SSenior VP - Drug Discovery
|
GrantEmp. Stock Option (Right to Buy) · Derivative | 235,000 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001127602-18-037173 · form4.xml · derivative · entry 1 Babu Yarlagadda S · CIK 0001452635 · Senior VP - Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,000 Underlying: Common Stock · 235,000 shares Expires 2028-12-20 F1 · shares: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:13 UTC |
Powell LynneSenior VP - CCO
|
GrantEmp. Stock Option (Right to Buy) · Derivative | 190,000 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001127602-18-037177 · form4.xml · derivative · entry 1 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2028-12-20 F1 · shares: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:08 UTC |
Sheridan William PSenior VP - CMO
|
GrantEmp. Stock Option (Right to Buy) · Derivative | 335,000 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001127602-18-037170 · form4.xml · derivative · entry 1 Sheridan William P · CIK 0001439174 · Senior VP - CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,000 Underlying: Common Stock · 335,000 shares Expires 2028-12-20 F1 · shares: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:06 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
GrantEmp. Stock Option (Right to Buy) · Derivative | 235,000 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001127602-18-037166 · form4.xml · derivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,000 Underlying: Common Stock · 235,000 shares Expires 2028-12-20 F1 · shares: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:05 UTC |
Stonehouse Jon PDirector · President & CEO
|
GrantEmp. Stock Option (Right to Buy) · Derivative | 675,000 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001127602-18-037163 · form4.xml · derivative · entry 1 Stonehouse Jon P · CIK 0001385496 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,000 Underlying: Common Stock · 675,000 shares Expires 2028-12-20 F1 · shares: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. Read SEC document |
| December 18, 2018 Filed Dec 20, 2018 21:37 UTC |
Sheridan William PSenior VP - CMO
|
SaleCommon Stock | 20,488 | $7.58 | $155,299.04 |
DisclosureSEC source: 0001127602-18-036977 · form4.xml · nonDerivative · entry 1 Sheridan William P · CIK 0001439174 · Senior VP - CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,725 F1 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.50 to $7.65. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:13 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-18-036067 · form4.xml · derivative · entry 6 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,427 Underlying: Common Stock · 2,000 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:13 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-18-036067 · form4.xml · derivative · entry 5 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,427 Underlying: Common Stock · 2,000 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:13 UTC |
Powell LynneSenior VP - CCO
|
SaleCommon Stock | 2,000 | $9.11 | $18,220.00 |
DisclosureSEC source: 0001127602-18-036067 · form4.xml · nonDerivative · entry 4 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.10 to $9.11. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:13 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionCommon Stock | 2,000 | $3.22 | $6,440.00 |
DisclosureSEC source: 0001127602-18-036067 · form4.xml · nonDerivative · entry 3 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:13 UTC |
Powell LynneSenior VP - CCO
|
SaleCommon Stock | 2,000 | $9.01 | $18,020.00 |
DisclosureSEC source: 0001127602-18-036067 · form4.xml · nonDerivative · entry 2 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.01. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:13 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionCommon Stock | 2,000 | $3.22 | $6,440.00 |
DisclosureSEC source: 0001127602-18-036067 · form4.xml · nonDerivative · entry 1 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 21:30 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 3,922 | $9.45 | $37,062.90 |
DisclosureSEC source: 0001127602-18-035386 · form4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,461 Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:34 UTC |
Stonehouse Jon PDirector · President & CEO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001127602-18-035394 · form4.xml · derivative · entry 3 Stonehouse Jon P · CIK 0001385496 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2018. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:34 UTC |
Stonehouse Jon PDirector · President & CEO
|
SaleCommon Stock | 80,000 | $9.12 | $729,600.00 |
DisclosureSEC source: 0001127602-18-035394 · form4.xml · nonDerivative · entry 2 Stonehouse Jon P · CIK 0001385496 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 727,674 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2018. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.93 to $9.27. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:34 UTC |
Stonehouse Jon PDirector · President & CEO
|
Exercise / conversionCommon Stock | 80,000 | $1.20 | $96,000.00 |
DisclosureSEC source: 0001127602-18-035394 · form4.xml · nonDerivative · entry 1 Stonehouse Jon P · CIK 0001385496 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 807,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2018. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:27 UTC |
HEGGIE THERESADirector
|
GrantNon-Qualified Stock Option · Derivative | 30,000 | $0.00 Strike: $9.27 | $0.00 |
DisclosureSEC source: 0001127602-18-035379 · form4.xml · derivative · entry 1 HEGGIE THERESA · CIK 0001760020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-12-03 F1 · shares: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan. Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 21:11 UTC |
Barnes Alane PSenior VP, Chief Legal Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001127602-18-035081 · form4.xml · derivative · entry 3 Barnes Alane P · CIK 0001584348 · Senior VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 21:11 UTC |
Barnes Alane PSenior VP, Chief Legal Officer
|
SaleCommon Stock | 44,290 | $9.07 | $401,710.30 |
DisclosureSEC source: 0001127602-18-035081 · form4.xml · nonDerivative · entry 2 Barnes Alane P · CIK 0001584348 · Senior VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,953 F1 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $9.00 to $9.19. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 21:11 UTC |
Barnes Alane PSenior VP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 25,000 | $1.42 | $35,500.00 |
DisclosureSEC source: 0001127602-18-035081 · form4.xml · nonDerivative · entry 1 Barnes Alane P · CIK 0001584348 · Senior VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 21:02 UTC |
Erck Stanley CDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 8,333 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001127602-18-034829 · form4.xml · derivative · entry 2 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,333 shares Expires 2018-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 21:02 UTC |
Erck Stanley CDirector
|
Exercise / conversionCommon Stock | 8,333 | $1.49 | $12,416.17 |
DisclosureSEC source: 0001127602-18-034829 · form4.xml · nonDerivative · entry 1 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2018 Filed Nov 26, 2018 21:19 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001127602-18-034301 · form4.xml · derivative · entry 9 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,305 Underlying: Common Stock · 3,500 shares Expires 2021-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. Read SEC document |
| November 23, 2018 Filed Nov 26, 2018 21:19 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 3,500 | $9.66 | $33,810.00 |
DisclosureSEC source: 0001127602-18-034301 · form4.xml · nonDerivative · entry 6 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,383 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. F4 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $9.65 to $9.69. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| November 23, 2018 Filed Nov 26, 2018 21:19 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 3,500 | $3.78 | $13,230.00 |
DisclosureSEC source: 0001127602-18-034301 · form4.xml · nonDerivative · entry 5 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:22 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001127602-18-034303 · form4.xml · derivative · entry 4 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,427 Underlying: Common Stock · 12,000 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2018. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:22 UTC |
Powell LynneSenior VP - CCO
|
SaleCommon Stock | 2,455 | $9.01 | $22,119.55 |
DisclosureSEC source: 0001127602-18-034303 · form4.xml · nonDerivative · entry 3 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2018. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.01. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:22 UTC |
Powell LynneSenior VP - CCO
|
SaleCommon Stock | 12,000 | $9.06 | $108,720.00 |
DisclosureSEC source: 0001127602-18-034303 · form4.xml · nonDerivative · entry 2 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,455 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2018. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $8.80 to $9.31. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:22 UTC |
Powell LynneSenior VP - CCO
|
Exercise / conversionCommon Stock | 12,000 | $3.22 | $38,640.00 |
DisclosureSEC source: 0001127602-18-034303 · form4.xml · nonDerivative · entry 1 Powell Lynne · CIK 0001631667 · Senior VP - CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2018. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:19 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001127602-18-034301 · form4.xml · derivative · entry 8 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,805 Underlying: Common Stock · 7,000 shares Expires 2021-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:19 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001127602-18-034301 · form4.xml · derivative · entry 7 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 5,000 shares Expires 2023-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:19 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 7,000 | $9.08 | $63,560.00 |
DisclosureSEC source: 0001127602-18-034301 · form4.xml · nonDerivative · entry 4 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,383 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.95 to $9.21. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:19 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 7,000 | $3.78 | $26,460.00 |
DisclosureSEC source: 0001127602-18-034301 · form4.xml · nonDerivative · entry 3 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:19 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
SaleCommon Stock | 5,000 | $9.41 | $47,050.00 |
DisclosureSEC source: 0001127602-18-034301 · form4.xml · nonDerivative · entry 2 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,383 F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $9.40 to $9.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 21:19 UTC |
STAAB THOMAS R IISenior Vice President and CFO
|
Exercise / conversionCommon Stock | 5,000 | $5.45 | $27,250.00 |
DisclosureSEC source: 0001127602-18-034301 · form4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.